Publication
Article
Pharmaceutical Executive
Author(s):
TKTKTKTKTKTK
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Spine BioPharma’s TGF-β Antagonist Misses Primary Endpoint in Phase III Degenerative Disc Disease Trial
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
Fatal Adverse Event Leads Allogene to Discontinue Novel Monoclonal Antibody, Adjust Cema-Cel Trial Protocol for Large B-Cell Lymphoma
Beyond the Prescription: Pharma's Role in Digital Health Conversations
GAIN Therapeutics Ramps Up for Next Big Step in Parkinson’s Drug Development
Computational Chemistry in Drug Discovery: Q&A with Dr. Peter Tummino